Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy-Reference-Cited by-同舟云学术

Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy

Published:2021-08-08 Issue:1 Volume:129 Page:80-92
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Ambrosetti Damien¹²^ORCID,Coutts Michael³,Paoli Charlotte¹,Durand Matthieu⁴^ORCID,Borchiellini Delphine⁵,Montemagno Christopher²⁶⁷,Rastoin Olivia²⁷,Borderie Arnaud¹,Grepin Renaud⁶⁷,Rioux‐Leclercq Nathalie⁸,Bernhard Jean‐Christophe⁹¹⁰,Pagès Gilles²⁶⁷,Dufies Maeva⁶⁷

Affiliation:

1. Department of Pathology CHU Nice Université Côte d’Azur NiceFrance

2. Institute for Research on Cancer and Aging of Nice (IRCAN) CNRS UMR 7284 INSERM U1081 University Côte d’Azur Nice France

3. Department of Pathology Maidstone General Hospital Maidstone UK

4. Department of Urology CHU Nice Université Côte d'Azur NiceFrance

5. Department of Oncology Centre Antoine Lacassagne Nice France

6. Department of Biomedical Centre Scientifique de Monaco MonacoPrincipality of Monaco

7. LIA ROPSE Laboratoire International Associé Université Côte d’Azur – Centre Scientifique de Monaco Monaco Principality of Monaco

8. Department of Pathology University Hospital RennesFrance

9. Department of Urology University Hospital BordeauxFrance

10. French Research Network on Kidney Cancer UroCCR Bordeaux France

Funder

Fondation de France

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15506

Reference42 articles.

1. Contemporary age‐adjusted incidence and mortality rates of renal cell carcinoma: analysis according to gender, race, stage, grade, and histology;Palumbo C;Eur Urol Focus,2020

2. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

3. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

4. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma

5. Resistance to targeted therapy in renal-cell carcinoma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer;Cells;2023-10-23

2. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics;British Journal of Pharmacology;2023-10-19

3. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers;Frontiers in Cell and Developmental Biology;2023-10-03

4. Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors;Translational Oncology;2023-09

5. Advanced in vitro models for renal cell carcinoma therapy design;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09